2-Aminotetralin: Difference between revisions
Content deleted Content added
Fix. |
Improve ref, tweaks. |
||
| Line 41: | Line 41: | ||
}} |
}} |
||
'''2-Aminotetralin''' ('''2-AT'''), also known as '''1,2,3,4-tetrahydronaphthalen-2-amine''' ('''THN'''), is a [[stimulant]] [[drug]] with a [[chemical structure]] consisting of a [[tetralin]] [[functional group|group]] combined with an [[amine]].<ref name=" |
'''2-Aminotetralin''' ('''2-AT'''), also known as '''1,2,3,4-tetrahydronaphthalen-2-amine''' ('''THN'''), is a [[stimulant]] [[drug]] with a [[chemical structure]] consisting of a [[tetralin]] [[functional group|group]] combined with an [[amine]].<ref name="OberlenderNichols1991">{{cite journal | vauthors = Oberlender R, Nichols DE | s2cid = 19069907 | title = Structural variation and (+)-amphetamine-like discriminative stimulus properties | journal = Pharmacology, Biochemistry, and Behavior | volume = 38 | issue = 3 | pages = 581–586 | date = March 1991 | pmid = 2068194 | doi = 10.1016/0091-3057(91)90017-V | url = https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=77437efa02b4a0f688e4038b153ddfafde6da614 | quote = In previous studies, 2-AT either did not stimulate spontaneous motor activity in mice (1,8), or it had 10% of the activity of amphetamine (24). Yet, in the present study, it mimicked (+)-amphetamine as a DS in rats, in agreement with the results of Glennon et al. (7). However, 2-AT was one-half as potent as (+)-amphetamine in that study but only one-eighth as potent as (+)-amphetamine in the present experiment. }}</ref><ref name="MarleyStephenson1971">{{cite journal | vauthors = Marley E, Stephenson JD | title = Actions of dexamphetamine and amphetamine-like amines in chickens with brain transections | journal = British Journal of Pharmacology | volume = 42 | issue = 4 | pages = 522–542 | date = August 1971 | pmid = 5116035 | pmc = 1665761 | doi = 10.1111/j.1476-5381.1971.tb07138.x }}</ref> |
||
2-AT is a rigid [[structural analog|analogue]] of [[phenylisobutylamine]] and fully substitutes for [[dextroamphetamine|d-amphetamine]] in rat [[drug discrimination]] tests, although at one-half to one-eighth the [[potency (pharmacology)|potency]].<ref name=" |
2-AT is a rigid [[structural analog|analogue]] of [[phenylisobutylamine]] and fully substitutes for [[dextroamphetamine|d-amphetamine]] in rat [[drug discrimination]] tests, although at one-half to one-eighth the [[potency (pharmacology)|potency]].<ref name="OberlenderNichols1991" /><ref name="GlennonYoungHauck1984">{{cite journal | vauthors = Glennon RA, Young R, Hauck AE, McKenney JD | title = Structure-activity studies on amphetamine analogs using drug discrimination methodology | journal = Pharmacol Biochem Behav | volume = 21 | issue = 6 | pages = 895–901 | date = December 1984 | pmid = 6522418 | doi = 10.1016/s0091-3057(84)80071-4 | url = }}</ref> It showed greater potency than a variety of other amphetamine homologues, including [[2-aminoindane]] (2-AI), [[naphthylaminopropane|1-naphthylaminopropane]] (1-NAP), [[2-naphthylaminopropane]] (2-NAP), [[phenylpiperazine|1-phenylpiperazine]] (1-PP), {{Abbrlink|6-AB|6-amino-6,7,8,9-tetrahydro-5H-benzocycloheptene}}, and {{Abbrlink|7-AB|7-amino-6,7,8,9-tetrahydro-5H-benzocycloheptene}}.<ref name="GlennonYoungHauck1984" /> |
||
2-AT has been shown to [[reuptake inhibitor|inhibit]] the [[reuptake]] of [[serotonin]] and [[norepinephrine]], and might induce their [[transporter reversal|release]] as well.<ref name=" |
2-AT has been shown to [[reuptake inhibitor|inhibit]] the [[reuptake]] of [[serotonin]] and [[norepinephrine]], and might induce their [[transporter reversal|release]] as well.<ref name="Bruinvels1971">{{cite journal | vauthors = Bruinvels J | title = Evidence for inhibition of the reuptake of 5-hydroxytryptamine and noradrenaline by tetrahydronaphthylamine in rat brain | journal = British Journal of Pharmacology | volume = 42 | issue = 2 | pages = 281–286 | date = June 1971 | pmid = 5091160 | pmc = 1667157 | doi = 10.1111/j.1476-5381.1971.tb07109.x }}</ref><ref name="BruinvelsKemper1971">{{cite journal | vauthors = Bruinvels J, Kemper GC | title = Role of noradrenaline and 5-hydroxytryptamine in tetrahydronaphthylamine-induced temperature changes in the rat | journal = British Journal of Pharmacology | volume = 43 | issue = 1 | pages = 1–9 | date = September 1971 | pmid = 4257629 | pmc = 1665934 | doi = 10.1111/j.1476-5381.1971.tb07151.x }}</ref> It is also likely to act on [[dopamine]] on account of its full substitution of d-amphetamine in [[animal testing on rodents|rodent studies]].<ref name="OberlenderNichols1991" /><ref name="GlennonYoungHauck1984" /> |
||
== Chemical derivatives == |
== Chemical derivatives == |
||
Revision as of 02:07, 8 December 2024
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.019.067 |
| Chemical and physical data | |
| Formula | C10H13N |
| Molar mass | 147.221 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
2-Aminotetralin (2-AT), also known as 1,2,3,4-tetrahydronaphthalen-2-amine (THN), is a stimulant drug with a chemical structure consisting of a tetralin group combined with an amine.[1][2]
2-AT is a rigid analogue of phenylisobutylamine and fully substitutes for d-amphetamine in rat drug discrimination tests, although at one-half to one-eighth the potency.[1][3] It showed greater potency than a variety of other amphetamine homologues, including 2-aminoindane (2-AI), 1-naphthylaminopropane (1-NAP), 2-naphthylaminopropane (2-NAP), 1-phenylpiperazine (1-PP), 6-AB, and 7-AB.[3]
2-AT has been shown to inhibit the reuptake of serotonin and norepinephrine, and might induce their release as well.[4][5] It is also likely to act on dopamine on account of its full substitution of d-amphetamine in rodent studies.[1][3]
Chemical derivatives
A number of derivatives of 2-aminotetralin exist, including:
See also
References
- ^ a b c Oberlender R, Nichols DE (March 1991). "Structural variation and (+)-amphetamine-like discriminative stimulus properties". Pharmacology, Biochemistry, and Behavior. 38 (3): 581–586. doi:10.1016/0091-3057(91)90017-V. PMID 2068194. S2CID 19069907.
In previous studies, 2-AT either did not stimulate spontaneous motor activity in mice (1,8), or it had 10% of the activity of amphetamine (24). Yet, in the present study, it mimicked (+)-amphetamine as a DS in rats, in agreement with the results of Glennon et al. (7). However, 2-AT was one-half as potent as (+)-amphetamine in that study but only one-eighth as potent as (+)-amphetamine in the present experiment.
- ^ Marley E, Stephenson JD (August 1971). "Actions of dexamphetamine and amphetamine-like amines in chickens with brain transections". British Journal of Pharmacology. 42 (4): 522–542. doi:10.1111/j.1476-5381.1971.tb07138.x. PMC 1665761. PMID 5116035.
- ^ a b c Glennon RA, Young R, Hauck AE, McKenney JD (December 1984). "Structure-activity studies on amphetamine analogs using drug discrimination methodology". Pharmacol Biochem Behav. 21 (6): 895–901. doi:10.1016/s0091-3057(84)80071-4. PMID 6522418.
- ^ Bruinvels J (June 1971). "Evidence for inhibition of the reuptake of 5-hydroxytryptamine and noradrenaline by tetrahydronaphthylamine in rat brain". British Journal of Pharmacology. 42 (2): 281–286. doi:10.1111/j.1476-5381.1971.tb07109.x. PMC 1667157. PMID 5091160.
- ^ Bruinvels J, Kemper GC (September 1971). "Role of noradrenaline and 5-hydroxytryptamine in tetrahydronaphthylamine-induced temperature changes in the rat". British Journal of Pharmacology. 43 (1): 1–9. doi:10.1111/j.1476-5381.1971.tb07151.x. PMC 1665934. PMID 4257629.